Advertisement
Advertisement
U.S. markets open in 6 hours 15 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Allogene Therapeutics, Inc. (ALLO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.62-0.22 (-2.03%)
At close: 04:00PM EDT
10.60 -0.02 (-0.19%)
After hours: 05:49PM EDT
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
247
38,489
0
0
0
Operating Expense
308,395
294,281
258,243
202,008
192,842
Operating Income
-308,148
-255,792
-258,243
-202,008
-192,842
Net Non Operating Interest Income Expense
1,386
1,714
9,164
17,351
2,431
Other Income Expense
-929
-2,927
-1,142
-268
-21,211
Pretax Income
-307,691
-257,005
-250,221
-184,925
-211,622
Tax Provision
-
0
0
-331
-117
Net Income Common Stockholders
-307,691
-257,005
-250,221
-184,594
-211,505
Diluted NI Available to Com Stockholders
-307,691
-257,005
-250,221
-184,594
-211,505
Basic EPS
-
-1.89
-2.08
-1.83
-7.31
Diluted EPS
-
-1.89
-2.08
-1.83
-7.31
Basic Average Shares
-
135,820
120,370
101,061
28,948
Diluted Average Shares
-
135,820
120,370
101,061
28,948
Total Operating Income as Reported
-308,148
-255,792
-258,243
-202,008
-192,842
Total Expenses
308,395
294,281
258,243
202,008
192,842
Net Income from Continuing & Discontinued Operation
-307,691
-257,005
-250,221
-184,594
-211,505
Normalized Income
-307,691
-257,005
-250,221
-184,594
-211,505
Interest Income
1,386
1,714
9,164
17,351
5,789
Interest Expense
-
-
0
0
3,358
Net Interest Income
1,386
1,714
9,164
17,351
2,431
EBIT
-308,148
-255,792
-250,221
-184,925
-208,264
EBITDA
-294,209
-
-
-
-
Reconciled Depreciation
13,939
10,454
7,586
5,027
1,500
Net Income from Continuing Operation Net Minority Interest
-307,691
-257,005
-250,221
-184,594
-211,505
Total Unusual Items Excluding Goodwill
-
-
-
-
-21,211
Total Unusual Items
-
-
-
-
-21,211
Normalized EBITDA
-294,209
-245,338
-242,635
-179,898
-206,764
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement